Clinical Trial Update: Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tinzaparin and biomarker analyses after neoadjuvant treatment in epithelial ovarian cancer; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Innohep (tinzaparin)

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: RECRUITING